179 related articles for article (PubMed ID: 35673904)
1. [An injectable hydrogel/staple fiber composite for sustained release of CA4P and doxorubicin for combined chemotherapy of xenografted breast tumor in mice].
Wang T; Yang L; Xie Y; Cheng S; Xiong M; Luo X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):625-632. PubMed ID: 35673904
[TBL] [Abstract][Full Text] [Related]
2. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.
Cao D; Zhang X; Akabar MD; Luo Y; Wu H; Ke X; Ci T
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):181-191. PubMed ID: 30686051
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
[TBL] [Abstract][Full Text] [Related]
4. Nanogel-Incorporated Injectable Hydrogel for Synergistic Therapy Based on Sequential Local Delivery of Combretastatin-A4 Phosphate (CA4P) and Doxorubicin (DOX).
Yang WJ; Zhou P; Liang L; Cao Y; Qiao J; Li X; Teng Z; Wang L
ACS Appl Mater Interfaces; 2018 Jun; 10(22):18560-18573. PubMed ID: 29767951
[TBL] [Abstract][Full Text] [Related]
5. Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy.
Zhong Y; Zhang L; Sun S; Zhou Z; Ma Y; Hong H; Yang D
J Nanobiotechnology; 2021 Oct; 19(1):333. PubMed ID: 34688292
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of Thermo-responsive Gel in pH-sensitive Polymersomes as Dual-Responsive Smart carriers for Controlled Release of Doxorubicin.
Oroojalian F; Babaei M; Taghdisi SM; Abnous K; Ramezani M; Alibolandi M
J Control Release; 2018 Oct; 288():45-61. PubMed ID: 30171978
[TBL] [Abstract][Full Text] [Related]
7. Drug-loaded implantable surgical cavity-adaptive hydrogels for prevention of local tumor recurrence.
Zhuang B; Chen T; Xiao Z; Jin Y
Int J Pharm; 2020 Mar; 577():119048. PubMed ID: 31978462
[TBL] [Abstract][Full Text] [Related]
8. A novel injectable phospholipid gel co-loaded with doxorubicin and bromotetrandrine for resistant breast cancer treatment by intratumoral injection.
Luo JW; Zhang T; Zhang Q; Cao X; Zeng X; Fu Y; Zhang ZR; Gong T
Colloids Surf B Biointerfaces; 2016 Apr; 140():538-547. PubMed ID: 26628333
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
[TBL] [Abstract][Full Text] [Related]
10. Nano-delivery vehicle based on chlorin E6, photodynamic therapy, doxorubicin chemotherapy provides targeted treatment of HER-2 negative, ανβ3-positive breast cancer.
He Z; Jiang H; Zhang X; Zhang H; Cui Z; Sun L; Li H; Qian J; Ma J; Huang J
Pharmacol Res; 2020 Oct; 160():105184. PubMed ID: 32946931
[TBL] [Abstract][Full Text] [Related]
11. An injectable thermosensitive photothermal-network hydrogel for near-infrared-triggered drug delivery and synergistic photothermal-chemotherapy.
Liu C; Guo X; Ruan C; Hu H; Jiang BP; Liang H; Shen XC
Acta Biomater; 2019 Sep; 96():281-294. PubMed ID: 31319202
[TBL] [Abstract][Full Text] [Related]
12. Thermo-sensitive polypeptide hydrogel for locally sequential delivery of two-pronged antitumor drugs.
Wei L; Chen J; Zhao S; Ding J; Chen X
Acta Biomater; 2017 Aug; 58():44-53. PubMed ID: 28576715
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation-Chemoembolization Therapy in Rats.
Li J; Zhou M; Liu F; Xiong C; Wang W; Cao Q; Wen X; Robertson JD; Ji X; Wang YA; Gupta S; Li C
Radiology; 2016 Nov; 281(2):427-435. PubMed ID: 27347765
[TBL] [Abstract][Full Text] [Related]
14. Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity.
Lin Z; Gao W; Hu H; Ma K; He B; Dai W; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2014 Jan; 174():161-70. PubMed ID: 24512789
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin.
Ren S; Dai Y; Li C; Qiu Z; Wang X; Tian F; Zhou S; Liu Q; Xing H; Lu Y; Chen X; Li N
Eur J Pharm Sci; 2016 Sep; 92():137-45. PubMed ID: 27388491
[TBL] [Abstract][Full Text] [Related]
16. Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery.
Chen X; Wang M; Yang X; Wang Y; Yu L; Sun J; Ding J
Theranostics; 2019; 9(21):6080-6098. PubMed ID: 31534538
[TBL] [Abstract][Full Text] [Related]
17. Co-Encapsulation of Combretastatin-A4 Phosphate and Doxorubicin in Polymersomes for Synergistic Therapy of Nasopharyngeal Epidermal Carcinoma.
Zhu J; Xu X; Hu M; Qiu L
J Biomed Nanotechnol; 2015 Jun; 11(6):997-1006. PubMed ID: 26353589
[TBL] [Abstract][Full Text] [Related]
18. Localized controlled release of bevacizumab and doxorubicin by thermo-sensitive hydrogel for normalization of tumor vasculature and to enhance the efficacy of chemotherapy.
Darge HF; Andrgie AT; Hanurry EY; Birhan YS; Mekonnen TW; Chou HY; Hsu WH; Lai JY; Lin SY; Tsai HC
Int J Pharm; 2019 Dec; 572():118799. PubMed ID: 31678386
[TBL] [Abstract][Full Text] [Related]
19. Development of self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system for liver cancer chemotherapy.
Nittayacharn P; Nasongkla N
J Mater Sci Mater Med; 2017 Jul; 28(7):101. PubMed ID: 28534285
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of doxorubicin-loaded pH-sensitive polymeric micelle release from tumor blood vessels and anticancer efficacy using a dorsal skin-fold window chamber model.
Jin ZH; Jin MJ; Jiang CG; Yin XZ; Jin SX; Quan XQ; Gao ZG
Acta Pharmacol Sin; 2014 Jun; 35(6):839-45. PubMed ID: 24902790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
